Brief: Sun Pharmaceutical Industries Says Co, SPARC Enter Worldwide License Agreement For SCD-044

Sun Pharma Advanced Research

28/05/2020 15:32

May 28 (Reuters) - Sun Pharma Advanced Research Co Ltd
 SPRC.NS :
    * SUN PHARMACEUTICAL INDUSTRIES LTD - SPARC AND SUN PHARMA
ENTER
INTO A WORLDWIDE LICENSE AGREEMENT FOR SCD-044
    * SUN PHARMACEUTICAL INDUSTRIES LTD - SCD-044 IS A POTENTIAL
TREATMENT FOR ATOPIC DERMATITIS, PSORIASIS AND OTHER AUTO-IMMUNE
DISORDERS
    * SUN PHARMACEUTICAL INDUSTRIES LTD SAYS  UNDER TERMS OF
LICENSE
AGREEMENT, SUN PHARMA WILL PAY SPARC AN UPFRONT PAYMENT OF US$
20 MILLION
    * SUN PHARMACEUTICAL INDUSTRIES LTD - SPARC WILL ALSO BE
ELIGIBLE
TO RECEIVE UP TO $125 MILLION AS MILESTONE PAYMENTS

Source text for Eikon:  ID:nBSE5xbBT7 
Further company coverage:  SPRC.NS 

 ((Reuters.Briefs@thomsonreuters.com;))